Skip to content

Clinical trials

Terminated Fatty Liver trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Status: Terminated Country / region: United States Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20062
20071
20084
20091
20151
20162
20171
20181
20192
20202
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)2
Sanofi2
AdventHealth Translational Research Institute1
Alnylam Pharmaceuticals1
AstraZeneca1
Beth Israel Medical Center1
Boston University1
Children's Hospital Medical Center, Cincinnati1
Corewell Health East1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver24
Non-alcoholic Fatty Liver Disease14
Insulin Resistance3
Liver Diseases3
Diabetes Mellitus2
Fibrosis2
Liver Cirrhosis2
Diabetes Complications1
Diabetes Mellitus, Type 21
Digestive System Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.